Sphingosine-1-phosphate receptor 1 (S1P receptor 1 or S1P1), also known as endothelial differentiation gene 1 (EDG1) is a protein that in humans is encoded by the S1PR1 gene. S1PR1 is a G-protein-coupled receptor which binds the bioactive signaling molecule sphingosine 1-phosphate (S1P). S1PR1 belongs to a sphingosine-1-phosphate receptor subfamily comprising five members (S1PR1-5). S1PR1 was originally identified as an abundant transcript in endothelial cells and it has an important role in regulating endothelial cell cytoskeletal structure, migration, capillary-like network formation and vascular maturation. In addition, S1PR1 signaling is important in the regulation of lymphocyte maturation, migration and trafficking.
Sphingosine 1-Phosphate Receptor 1 Market aims to provide a comprehensive presentation of the global market for Sphingosine 1-Phosphate Receptor 1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sphingosine 1-Phosphate Receptor 1. Sphingosine 1-Phosphate Receptor 1 Market contains market size and forecasts of Sphingosine 1-Phosphate Receptor 1 in global, including the following market information:
- Global Sphingosine 1-Phosphate Receptor 1 Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global Sphingosine 1-Phosphate Receptor 1 Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Sphingosine 1-Phosphate Receptor 1 companies in 2022 (%)
The global Sphingosine 1-Phosphate Receptor 1 market was valued at US$ 3486.4 million in 2022 and is projected to reach US$ 5990.1 million by 2029, at a CAGR of 8.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In the last several years, global market of Sphingosine 1-Phosphate Receptor 1 developed rapidly, with an average growth rate of 3.5%, Sphingosine 1-Phosphate Receptor 1 is widely used in Hospital, Clinic. North America is the largest consumption place, with a revenue market share nearly 57.1% in 2019,. and market competition is not intense.
We surveyed the Sphingosine 1-Phosphate Receptor 1 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sphingosine 1-Phosphate Receptor 1 Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Sphingosine 1-Phosphate Receptor 1 Market Segment Percentages, by Type, 2022 (%)
- Fingolimod
- Siponimod
- Ozanimod
- Other
Global Sphingosine 1-Phosphate Receptor 1 Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Sphingosine 1-Phosphate Receptor 1 Market Segment Percentages, by Application, 2022 (%)
Global Sphingosine 1-Phosphate Receptor 1 Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Sphingosine 1-Phosphate Receptor 1 Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Sphingosine 1-Phosphate Receptor 1 revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Sphingosine 1-Phosphate Receptor 1 revenues share in global market, 2022 (%)
- Key companies Sphingosine 1-Phosphate Receptor 1 sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Sphingosine 1-Phosphate Receptor 1 sales share in global market, 2022 (%)
- Further, the report presents profiles of competitors in the market, key players include:
- Novartis AG
- Bristol-Myers Squibb Company
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Sphingosine 1-Phosphate Receptor 1, market overview.
- Chapter 2: Global Sphingosine 1-Phosphate Receptor 1 market size in revenue and volume.
- Chapter 3: Detailed analysis of Sphingosine 1-Phosphate Receptor 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Sphingosine 1-Phosphate Receptor 1 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: Global Sphingosine 1-Phosphate Receptor 1 capacity by region & country.
- Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
- Chapter 11: The main points and conclusions of the report.